Plain-English translation of NCT06927648 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This is a real-world safety and effectiveness study of Capivasertib, a medication approved for breast cancer treatment in South Korea. Researchers want to understand how well this medication works and how safe it is when used by patients in everyday medical practice, rather than in a controlled research setting. Your participation helps doctors learn what happens when the medication is used outside of a clinical trial.
After a medication is approved and available to patients, it's important to monitor how it performs in real-world settings where patients have different ages, health conditions, and circumstances than those in the original approval studies. This study helps make sure the medication remains safe and effective for all patients who receive it.
You likely qualify if…
You likely don't qualify if…
As a participant, you would continue taking your prescribed medication as usual. The study team would collect information about your safety and how well the treatment is working through your regular medical visits and records. There are no additional visits or procedures required beyond your standard cancer care.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
South Korea